Get started
Award

Abuse Liability Associated with Chronic Hypnotic Use

Funding type: research
Funder scheme: R01
Start date: 2004-08-15
End date: 2010-05-31
Investigator: TIMOTHY A ROEHRS
Institution: HENRY FORD HEALTH SYSTEM
Funded outputs count: 11
Funder award ID: R01DA017355
OpenAlex ID: G1967581325
Hyperarousal in insomnia: pre-sleep and diurnal cortisol levels in response to chronic zolpidem treatment
2019 · Timothy Roehrs, Thomas Roth · Sleep Medicine · 17
How representative are insomnia clinical trials?
2018 · T. Roehrs, J.C. Verster, et al. · Sleep Medicine · 11
PDF
Hyperarousal in insomnia and hypnotic dose escalation
2016 · T.A. Roehrs, T. Roth · Sleep Medicine · 14
Gender Differences in the Efficacy and Safety of Chronic Nightly Zolpidem
2016 · Timothy A. Roehrs, Thomas Roth · Journal of Clinical Sleep Medicine · 27
Sleep Disturbance in Substance Use Disorders
2015 · Timothy A. Roehrs, Thomas Roth · Psychiatric Clinics of North America · 130
Efficacy of Eight Months of Nightly Zolpidem: A Prospective Placebo-Controlled Study
2012 · Surilla Randall, Timothy A. Roehrs, et al. · SLEEP · 92
Insomnia Pharmacotherapy
2012 · Timothy Roehrs, Thomas Roth · Neurotherapeutics · 133
PDF
MSLT in Primary Insomnia: Stability and Relation to Nocturnal Sleep
2011 · Timothy A. Roehrs, Surilla Randall, et al. · SLEEP · 84
PDF
Twelve months of nightly zolpidem does not lead to rebound insomnia or withdrawal symptoms: a prospective placebo-controlled study
2011 · Timothy A Roehrs, S Randall, et al. · Journal of Psychopharmacology · 94
Twelve Months of Nightly Zolpidem Does Not Lead to Dose Escalation: A Prospective Placebo-Controlled Study
2011 · Timothy A. Roehrs, Surilla Randall, et al. · SLEEP · 42
PDF
Drug-Related Sleep Stage Changes: Functional Significance and Clinical Relevance
2010 · Timothy Roehrs, Thomas Roth · Sleep Medicine Clinics · 66
Year
Topic